STOCK TITAN

Cardlytics (CDLX) Stock News

CDLX NASDAQ

Cardlytics reports as a Nasdaq-listed commerce media platform that connects advertisers with consumers through publishers’ digital channels and a card-linked offer network. Company updates commonly cover revenue, billings, consumer incentives, partner-share costs, adjusted contribution, Adjusted EBITDA, and guidance tied to advertiser demand and publisher relationships.

Recurring announcements also address governance and equity compensation under its inducement plan, capital-structure matters, and strategic portfolio actions. Recent company history includes the completed divestiture of Bridg, the identity resolution and shopper intelligence platform that had used point-of-sale data for analytics, loyalty marketing, and measurement.

Rhea-AI Summary

Cardlytics (CDLX) will release its third-quarter 2026 financial results on November 5, 2026, after the market closes.

The quarter ended September 30, 2026. A conference call will follow at 5:00 pm Eastern time, with a live audio webcast on the company’s investor relations website and a replay available afterward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.31%
Tags
earnings date
-
Rhea-AI Summary

Cardlytics (CDLX) announced a partnership with Rove to bring its card-linked offers program to the travel rewards platform’s members.

The partnership extends the Cardlytics Rewards Platform to Rove. Members can link a card to earn rewards automatically through personalized offers, adding a way to earn Rove Miles without requiring a travel credit card.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.8%
Tags
none
-
Rhea-AI Summary

Similarweb (SMWB) appointed Michael Akkerman chief executive officer effective November 2, 2026, succeeding founder Or Offer. Offer’s decision to step down after close to two decades as CEO was previously announced in May 2026. He will remain involved during a transition period to support Akkerman and the board.

Akkerman currently serves as chief business officer of Digital Turbine (APPS), overseeing sales, partnerships, marketing, product and business operations. He previously led go-to-market functions at data.ai and held product and strategy leadership at Cardlytics (CDLX). He also held senior commercial roles at Uber (UBER) and Pinterest (PINS). Akkerman will lead Similarweb from its New York office. Similarweb said the appointment does not change its strategy, operations or financial outlook.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported second quarter 2026 revenue of $36.9 million, down 36% year-over-year, and Billings of $65.5 million, down 34%. Adjusted Contribution was $21.3 million (–32% YoY), and Net Loss widened to $(14.9) million. Adjusted EBITDA was $1.7 million, compared with $3.0 million a year earlier.

Net loss per share from continuing operations was $(1.50) versus $(1.15), while Adjusted Net Loss per share was $(0.81) versus $(0.60). Operating cash flow was $(8.6) million and Free Cash Flow was $(10.7) million. MQUs declined 17% to 185.4 million, and ACPU fell to $0.11 from $0.14.

For the third quarter 2026, Cardlytics expects Billings of $61–$67 million, Revenue of $34–$39 million, Adjusted Contribution of $20–$23 million, and Adjusted EBITDA between $0 and $3 million, all implying year-over-year declines.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.94%
Tags
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported that on August 3, 2026 it granted an aggregate of 50,000 restricted stock units (RSUs) to its newly appointed Chief Legal Officer, Chris Cheng. According to Cardlytics, the award was approved as a material inducement to Cheng’s employment under Nasdaq Listing Rule 5635(c)(4) and issued pursuant to the company’s 2022 Inducement Plan.

The RSUs will vest over 24 months: 25,000 shares are scheduled to vest on September 1, 2027, with the remaining 25,000 shares vesting quarterly over the following 12 months, in each case subject to Cheng’s continued service with Cardlytics through the applicable vesting dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
none
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported that on July 29, 2026, its Board’s Compensation Committee granted an aggregate of 10,320 restricted stock units (RSUs) to 10 newly hired employees. The awards were issued as material inducements to employment under Nasdaq Listing Rule 5635(c)(4) and made pursuant to the 2022 Inducement Plan.

According to Cardlytics, for each recipient, 50% of the RSUs vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the following 12 months, subject to continuous service and the terms of the 2022 Inducement Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
none
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. He will join the Leadership Team and lead the Legal and Compliance organization. Cheng succeeds former Chief Legal Officer Nick Lynton, who departed in July 2026.

According to Cardlytics, Cheng brings over 20 years of legal leadership at high‑growth technology and public companies, including senior roles at Zoom, Uber, Upwork, eBay, and most recently as Chief Legal Officer and Corporate Secretary at Iterable.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) will release its financial results for the quarter ended June 30, 2026 on August 5, 2026, after market close. Management will host a conference call and live audio webcast at 5:00 p.m. Eastern / 2:00 p.m. Pacific, accessible via the Cardlytics investor relations website, with a replay available afterward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
earnings date
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported Q1 2026 results: Revenue $34.3M, Billings $58.1M, and Adjusted Contribution $19.7M. The company completed the Bridg divestiture on March 24, 2026 and liquidated PAR shares to strengthen the balance sheet. Adjusted EBITDA turned positive to $0.2M and net loss narrowed to $4.5M. Q2 2026 guidance: Billings $61.0–$67.0M; Revenue $35.0–$40.0M; Adjusted Contribution $20.0–$23.0M.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.15%
Tags
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) announced that on April 29, 2026 the Compensation Committee granted an aggregate of 272,000 restricted stock units to six newly hired employees as inducements under the 2022 Inducement Plan pursuant to Nasdaq Listing Rule 5635(c)(4). 50% vests at one year; remaining 50% vests quarterly over the next 12 months, subject to continuous service and plan terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.75%
Tags
none

FAQ

What is the current stock price of Cardlytics (CDLX)?

Cardlytics (CDLX) last closed at $1.6.

What is the market cap of Cardlytics (CDLX)?

The market cap of Cardlytics (CDLX) is approximately $9.4M.